NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Barnes & Noble Education, Inc. ("Barnes & Noble" or the "Company") (NYSE:BNED). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Barnes & Noble […]
NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of MarineMax, Inc. ("MarineMax" or the "Company") (NYSE:HZO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether MarineMax and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ:TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Telix and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Exelixis, Inc. ("Exelixis" or the "Company") (NASDAQ:EXEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Exelixis and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ:NEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether NeoGenomics and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Praxis Precision Medicines, Inc. ("Praxis" or the "Company") (NASDAQ:PRAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Praxis and certain of its officers
NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fluor Corporation ("Fluor" or the "Company") (NYSE:FLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Fluor and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Spirit Aviation Holdings, Inc.("Spirit" or the "Company") (NYSE:FLYY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Spirit and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Innovative Solutions and Support, Inc. ("IS&S" or the "Company") (NASDAQ:ISSC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether IS&S and certain of its
No KYC. 100x Leverage. $50 Welcome Bonus. Crypto Futures Trading Made Easy on BexBack. GlobeNewswire August 30, 2025 SINGAPORE, Aug. 30, 2025 (GLOBE NEWSWIRE) — With the return of the bull market and Bitcoin reaching new all-time highs, BexBack is helping traders quickly build wealth by offering 100x leverage and a double deposit bonus, with